biAb Mediated Restoration of the Linkage between Dystroglycan and Laminin-211 as a Therapeutic Approach for α-Dystroglycanopathies
Open Access
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 28 (2) , 664-676
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Kinetic mechanism of controlled Fab-arm exchange for the formation of bispecific immunoglobulin G1 antibodiesJournal of Biological Chemistry, 2018
- Efficacy of Gene Therapy Is Dependent on Disease Progression in Dystrophic Mice with Mutations in the FKRP GeneMolecular Therapy - Methods & Clinical Development, 2017
- Engineering adeno-associated viruses for clinical gene therapyNature Reviews Genetics, 2014
- Adeno-Associated Viral-Mediated LARGE Gene Therapy Rescues the Muscular Dystrophic Phenotype in Mouse Models of DystroglycanopathyHuman Gene Therapy, 2013
- Glycomic Analyses of Mouse Models of Congenital Muscular DystrophyJournal of Biological Chemistry, 2011
- Sarcoglycanopathies: molecular pathogenesis and therapeutic prospectsExpert Reviews in Molecular Medicine, 2009
- Preservation of Muscle Force in Mdx3cv Mice Correlates with Low-Level Expression of a Near Full-Length Dystrophin ProteinThe American Journal of Pathology, 2008
- Cys669–Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit associationGenes to Cells, 2006
- The Crystal Structure of a Laminin G–like Module Reveals the Molecular Basis of α-Dystroglycan Binding to Laminins, Perlecan, and AgrinMolecular Cell, 1999
- Recombinant human IgG molecules lacking Fcγ receptor I binding and monocyte triggering activitiesEuropean Journal of Immunology, 1999